Evidence Required for Drugs Granted Accelerated Approval Reply

被引：0

作者：

Naci, Huseyin ^{[1
]}

Kesselheim, Aaron S. ^{[2
]}

机构：

[1] London Sch Econ & Polit Sci, Dept Hlth Policy, London, England

[2] Brigham & Womens Hosp, Program Regulat Therapeut & Law PORTAL, 75 Francis St, Boston, MA 02115 USA

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2017年 / 318卷 / 24期

关键词：

D O I：

10.1001/jama.2017.17184

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2493 / 2494

页数：2

共 50 条

[1] Evidence Required for Drugs Granted Accelerated Approval
Tanimoto, Tetsuya
Kosugi, Kazuhiro
Tsuda, Kenji
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (24): : 2492 - 2493
[2] Accelerated Approval for Cancer Drugs in the United States and the Clinical Evidence Required for Conversion to Regular Approval
Kato, Satoshi
Ono, Shunsuke
[J]. JOURNAL OF PHARMACEUTICAL INNOVATION, 2024, 19 (05)
[3] Balancing Accelerated Approval for Drugs With Accelerated Withdrawal Reply
Kim, Chul
Prasad, Vinay
[J]. JAMA INTERNAL MEDICINE, 2016, 176 (04) : 567 - 567
[4] FDA granted accelerated approval to ibrutinib(IMBRUVICA)
[J]. Journal of Chinese Pharmaceutical Sciences, 2014, (04) : 273 - 273
[5] TIME TO APPROVAL OF NOVEL CANCER MEDICINES GRANTED ACCELERATED APPROVAL AND IMPLICATIONS FOR REFORM OF THE ACCELERATED APPROVAL PATHWAY
Hwang, Thomas
Tibau, Ariadna
[J]. JOURNAL OF UROLOGY, 2024, 211 (05): : E941 - E941
[6] Time to full approval of novel anticancer medicines granted accelerated approval and implications for reform of the accelerated approval pathway
Hwang, T.
Molto, C.
Puy, M. Borrell
Tibau, A.
[J]. ANNALS OF ONCOLOGY, 2023, 34 : S931 - S931
[7] US drugs were granted breakthrough approval on weak evidence, study finds
Wise, Jacqui
[J]. BMJ-BRITISH MEDICAL JOURNAL, 2018, 362
[8] Characteristics of Preapproval and Postapproval Studies for Drugs Granted Accelerated Approval by the US Food and Drug Administration
Naci, Huseyin
Smalley, Katelyn R.
Kesselheim, Aaron S.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (07): : 626 - 636
[9] First Treatment for Urothelial Cancer Granted Accelerated Approval
不详
[J]. BIOPHARM INTERNATIONAL, 2020, 33 (03) : 10 - 10
[10] Clinical Trial Evidence Supporting FDA Approval of Drugs Granted Breakthrough Therapy Designation
Puthumana, Jeremy
Wallach, Joshua D.
Ross, Joseph S.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (03): : 301 - 303

← 1 2 3 4 5 →